ROLE OF PLATELET ACTIVATING FACTOR AND TUMOR NECROSIS FACTOR-ALPHA IN NEONATAL NECROTIZING ENTEROCOLITIS
ROLE OF PLATELET ACTIVATING FACTOR AND TUMOR NECROSIS FACTOR-ALPHA IN NEONATAL NECROTIZING ENTEROCOLITIS
复制标题
DOI:
10.1016/s0022-3476(05)80661-4
复制
发表时间:
1990-06-01
影响因子:
5.1
通讯作者:
HAGEMAN, JR
中科院分区:
文献类型:
--
作者:
CAPLAN, MS;SUN, XM;HAGEMAN, JR
Because previous investigations have suggested that platelet activating factor and tumor necrosis factor-alpha (TNF-.alpha.) are important mediators of experimental necrotizing enterocolitis in the rat, we measured platelet activating factor, acetylhydrolase (the platelet activating factor breakdown enzyme) and TNF-.alpha. in the plasma of 12 human neonates with necrotizing enterocolitis and eight age-matched control subjects with similar gestational ages, postnatal ages, and weights. Almost all patients with necrotizing enterocolitis had elevated plasma platelet activating factor values (18.1 .+-. 3.6 ng/ml vs. 3.1 .+-. 0.9 ng/ml/min, in control subjects, p < 0.01). Plasma acetylhydrolase activity was lower in patients than in control subjects (10.6 .+-. 0.7 nmol/ml/min vs. 23.0 .+-. 1.4 nmol/ml/min, p < 0.01). Plasma TNF-.alpha. concentration was significantly elevated in patients with necrotizing enterocolitis (136 .+-. 75 U/ml vs 1.5 .+-. 0.8 U/ml, p < 0.05), although the individual variation was high. There was no correlation between individual TNF-.alpha. and platelet activating factor levels. We conclude that platelet activating factor and TNF-.alpha. are elevated in patients with necrotizing enterocolitis and that suppressed platelet activating factor degradation contributes to the increased platelet activating factor levels; platelet activating factor and TNF-.alpha. may contribute to the pathophysiology of necrotizing enterocolitis.